Goldman Sachs Group Inc. is seeking to sell a stake in Simon, its two-year-old web app that sells complex financial products to retail investors
NYS Entity Status
NYS Filing Date
MARCH 10, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2014 - BUSHWIC INVESTORS GROUP INC.
Around the Web
- Goldman Eyes Spinoff of Simon, an Online Tool for Bond Sales
Wednesday Jul 5, 2017
- A Slump in Tech Stocks That Leaves Some Investors Mystified
By LANDON THOMAS Jr. - Monday Jun 12, 2017
Shares of Netflix, Apple and other giant technology companies that have powered a market rally have taken an uncharacteristic pause.
- Softbank is ‘interested’ in an Uber or Lyft investment
By Reuters - Monday Aug 7, 2017
(Reuters) — SoftBank Group Corp, a prolific investor in global technology startups, reported a sharp rise in quarterly profits and said it would be interested in parking funds in ride-hailing firms Uber Technologies or Lyft Inc in the future. This is the first time Softbank has publicly indicated an interest in Uber, after having so far […]
- Uber Investors Clash With Board Over Voting Power
Monday Oct 2, 2017
Uber Technologies Inc.’s board is bracing for a contentious battle over voting control after two investors threatened legal action ahead of a planned vote Tuesday that could upend the board and diminish the power of some of the company’s earliest shareholders.
- Regeneron Touts Success in Big Asthma Drug Study, Plans FDA Filing
By Ben Fidler - Monday Sep 11, 2017
A new drug for patients who have a hard time controlling their asthma could be nearing an FDA review. Tarrytown, NY-based Regeneron Pharmaceuticals (NASDAQ: REGN) and partner Sanofi this morning are touting results this morning from a 1,902-patient Phase 3 study called Liberty Asthma Quest. In it, their injectable antibody drug dupilumab (Dupixent), already approved […]